Single Point Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,524
Closed -$201K 57
2024
Q1
$201K Buy
+1,524
New +$188K 0.05% 76
2023
Q3
Sell
-7,316
Closed -$844K 100
2023
Q2
$844K Buy
7,316
+834
+13% +$94.7K 1.16% 15
2023
Q1
$690K Buy
6,482
+2
+0% +$216 0.15% 58
2022
Q4
$719K Sell
6,480
-122
-2% -$12.5K 0.17% 51
2022
Q3
$569K Sell
6,602
-121
-2% -$10.8K 0.16% 58
2022
Q2
$613K Sell
6,723
-516
-7% -$45.7K 0.17% 51
2022
Q1
$594K Buy
7,239
+3,607
+99% +$284K 0.15% 52
2021
Q4
$278K Sell
3,632
-914
-20% -$72.8K 0.07% 66
2021
Q3
$341K Buy
4,546
+108
+2% +$8.21K 0.75% 16
2021
Q2
$348K Sell
4,438
-83
-2% -$6.17K 0.12% 51
2021
Q1
$333K Buy
4,521
+1,220
+37% +$90K 0.12% 59
2020
Q4
$258K Sell
3,301
-262
-7% -$20K 0.12% 58
2020
Q3
$282K Sell
3,563
-84
-2% -$6.58K 0.15% 53
2020
Q2
$269K Sell
3,647
-73
-2% -$5.5K 0.16% 53
2020
Q1
$275K Buy
3,720
+1,113
+43% +$87.5K 0.19% 53
2019
Q4
$226K Buy
+2,607
New +$214K 0.14% 60

Other funds holding MRK

Single Point Partners's MRK Position: Q2 2024 in Review

Single Point Partners sold out of Merck (MRK) in Q2 2024, closing a stake of 1,524 shares — an estimated $201K sold.

Single Point Partners first reported a position in MRK in Q4 2019 and held it in 16 quarters. The position peaked at $844K in Q2 2023. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Single Point Partners reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • Single Point Partners sold 1,524 Merck shares in Q2 2024, an estimated $201K.
  • Single Point Partners first reported a position in Merck in Q4 2019 and held it in 16 quarters.
  • Single Point Partners's Merck position peaked at $844K in Q2 2023.
  • 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Single Point Partners's 13F filing for Q2 2024, filed 12 Jul 2024.